Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

A New Clinical Scale for the Staging of Dementia

Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056 · see citing works

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130 · see citing works

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · see citing works

PET imaging of amyloid deposition in patients with mild cognitive impairment

Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 725 · see citing works

PET imaging of amyloid in Alzheimer's disease

Nordberg, A. K. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00853-1 · Cited by 462 · see citing works

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389 · see citing works

A total score for the CERAD neuropsychological battery

Chandler, M. J., Lacritz, L. H., Hynan, L. S., Barnard, H. D., Allen, G., Deschner, M., Weiner, M. F., & Cullum, C. M. (2005) · Neurology · doi:10.1212/01.wnl.0000167607.63000.38 · Cited by 387 · see citing works

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.

Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augustinack, J. C., Johnson, K. A., Irizarry, M. C., Klunk, W. E., Mathis, C. A., DeKosky, S. T., et al. (2007) · PubMed · doi:10.1001/archneur.64.3.431 · Cited by 341 · see citing works

PET amyloid ligand [ 11 C]PIB uptake is increased in mild cognitive impairment

Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., Viitanen, M. H., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000260969.94695.56 · Cited by 306 · see citing works

Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response

Golomb, J. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.6.778 · Cited by 279 · see citing works

Voxel-based analysis of PET amyloid ligand [ 11 C]PIB uptake in Alzheimer disease

Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., Viitanen, M. H., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000240117.55680.0a · Cited by 227 · see citing works

Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study

Archer, H. A., Edison, P., Brooks, D. J., Barnes, J., Frost, C. D., Yeatman, T., Fox, N. C., & Rossor, M. N. (2006) · Annals of Neurology · doi:10.1002/ana.20889 · Cited by 179 · see citing works

Five-Year Outcome of Normal Pressure Hydrocephalus with or Without a Shunt: Predictive Value of the Clinical Signs, Neuropsychological Evaluation and Infusion Test

Savolainen, S., Hurskainen, H., Paljärvi, L., Alafuzoff, I. I., & Vapalahti, M. P. (2002) · Acta Neurochirurgica · doi:10.1007/s00701-002-0936-3 · Cited by 178 · see citing works

Prevalence of Alzheimer's Disease in Patients Investigated for Presumed Normal Pressure Hydrocephalus: A Clinical and Neuropathological Study

Savolainen, S., Paljärvi, L., & Vapalahti, M. P. (1999) · Acta Neurochirurgica · doi:10.1007/s007010050386 · Cited by 157 · see citing works

The neuropsychology of normal pressure hydrocephalus (NPH)

DeVito, E. E., Pickard, J. D., Salmond, C. H., Iddon, J. L., Loveday, C., & Sahakian, B. J. (2005) · British Journal of Neurosurgery · doi:10.1080/02688690500201838 · Cited by 70 · see citing works

Brain Biopsy Prior to Treatment of Alzheimer's Disease

Holm, A., Savolainen, S., & Alafuzoff, I. I. (2003) · min - Minimally Invasive Neurosurgery · doi:10.1055/s-2003-40733 · Cited by 16 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099 · see citing works

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · see citing works

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

Clark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70142-4 · Cited by 855 · see citing works

<i>APOE</i> predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging

Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830 · see citing works

Prevalence of Amyloid PET Positivity in Dementia Syndromes: A Meta-analysis

Ossenkoppele, R., Jansen, W. J., Rabinovici, G. D., Knol, D. L., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Visser, P. J., Verfaillie, S. C. J., Zwan, M. D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4669 · Cited by 677 · see citing works

18 F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

Vandenberghe, R. R., Laere, K. V., Ivanoiu, A., Salmon, É., Bastin, C., Triau, E., Hasselbalch, S. G., Law, I. G., Andersen, A., Kørner, A., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22068 · Cited by 649 · see citing works

Appropriate use criteria for amyloid PET: a report of the amyloid imaging task force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., Karlawish, J. H., Rowe, C. C., Carrillo, M. C., Hartley, D. M., et al. (2013) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2013.01.002 · Cited by 603 · see citing works

Alzheimer Disease

Castellani, R. J., Rolston, R. K., & Smith, M. A. (2010) · Disease-a-Month · doi:10.1016/j.disamonth.2010.06.001 · Cited by 561 · see citing works

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

Jack, C. R., Wiste, H. J., Vemuri, P., Weigand, S. D., Senjem, M. L., Zeng, G., Bernstein, M. A., Gunter, J. L., Pankratz, V. S., Aisen, P. S., et al. (2010) · Brain · doi:10.1093/brain/awq277 · Cited by 531 · see citing works

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00108 · Cited by 480 · see citing works

The use of PET in Alzheimer disease

Nordberg, A. K., Rinne, J. O., Kadir, A., & Långström, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.217 · Cited by 451 · see citing works

Relationship between atrophy and β‐amyloid deposition in Alzheimer disease

Chételat, G., Villemagne, V. L., Bourgeat, P., Pike, K. E., Jones, G., Ames, D., Ellis, K. A., Szoeke, C., Martins, R. N., O'Keefe, G. J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21955 · Cited by 373 · see citing works

Amyloid‐β associated cortical thinning in clinically normal elderly

Becker, J. A., Hedden, T., Carmasin, J., Maye, J., Rentz, D. M., Putcha, D., Fischl, B., Greve, D. N., Marshall, G. A., Salloway, S., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22333 · Cited by 342 · see citing works

Phase 1 Study of the Pittsburgh Compound B Derivative 18 F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

Nelissen, N., Laere, K. V., Thurfjell, L., Owenius, R., Vandenbulcke, M., Koole, M. J. B., Bormans, G. M., Brooks, D. J., & Vandenberghe, R. R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063305 · Cited by 331 · see citing works

Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association

Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., Karlawish, J. H., Rowe, C. C., Carrillo, M. C., Hartley, D. M., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120618 · Cited by 329 · see citing works

Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B

Storandt, M., Mintun, M. A., Head, D. M., & Morris, J. C. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.272 · Cited by 304 · see citing works

Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden

Rabinovici, G. D., Furst, A. J., Alkalay, A., Racine, C. A., O’Neil, J. P., Janabi, M., Baker, S. L., Agarwal, N., Bonasera, S. J., Mormino, E. C., et al. (2010) · Brain · doi:10.1093/brain/awp326 · Cited by 280 · see citing works

Brain Amyloid Imaging

Rowe, C. C., & Villemagne, V. L. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076315 · Cited by 275 · see citing works

Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

Johnson, K. A., Sperling, R. A., Gidicsin, C. M., Carmasin, J. S., Maye, J. E., Coleman, R. E., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., et al. (2013) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2012.10.007 · Cited by 270 · see citing works

Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection

Teipel, S. J., Drzezga, A. E., Grothe, M. J., Barthel, H., Chételat, G., Schuff, N. W., Skudlarski, P., Cavedo, E., Frisoni, G. B., Hoffmann, W. U., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00093-9 · Cited by 263 · see citing works

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study

Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain · doi:10.1093/brain/aws125 · Cited by 255 · see citing works

18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)

Smailagic, N., Vacante, M., Hyde, C., Martin, S., Ukoumunne, O. C., & Sachpekidis, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010632.pub2 · Cited by 229 · see citing works

Impact of molecular imaging on the diagnostic process in a memory clinic

Ossenkoppele, R., Prins, N. D., Pijnenburg, Y. A. L., Lemstra, A. W., van der Flier, W. M., Adriaanse, S. F., Windhorst, A. D., Handels, R. L. H., Wolfs, C. A. G., Aalten, P., et al. (2013) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2012.07.003 · Cited by 194 · see citing works

Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia

Rowe, C. C., Pejoska, S., Mulligan, R. S., Jones, G. R., Chan, J. G., Svensson, S., Cselényi, Z., Masters, C. L., & Villemagne, V. L. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114785 · Cited by 193 · see citing works

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Rabinovici, G. D., & Jagust, W. J. (2009) · PubMed Central · doi:10.3233/ben-2009-0232 · Cited by 194 · see citing works

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease

Villemagne, V. L., Mulligan, R. S., Pejoska, S., Ong, K. T., Jones, G. R., O'Keefe, G. J., Chan, J. G., Young, K., Tochon‐Danguy, H., Masters, C. L., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2088-x · Cited by 190 · see citing works

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease

Yokokura, M., Mori, N., Yagi, S., Yoshikawa, E., Kikuchi, M., Yoshihara, Y., Wakuda, T., Sugihara, G., Takebayashi, K., Suda, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1612-0 · Cited by 174 · see citing works

PET amyloid-beta imaging in preclinical Alzheimer's disease

Vlassenko, A. G., Benzinger, T. L. S., & Morris, J. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.005 · Cited by 173 · see citing works

Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant

Mormino, E. C., Brandel, M. G., Madison, C. M., Rabinovici, G. D., Marks, S., Baker, S. L., & Jagust, W. J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.098 · Cited by 158 · see citing works

Association Between In Vivo Fluorine 18–Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology

Wolk, D. A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.153 · Cited by 156 · see citing works

Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus

Cabral, D., Beach, T. G., Vedders, L. J., Sue, L. I., Jacobson, S. A., Myers, K. W., & Sabbagh, M. N. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.008 · Cited by 155 · see citing works

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J. K., Tamminen, J. N., Tillgren, T., Vainikka, S., Pyykkö, O. T., Mölsä, J. A. A., zu Fraunberg, M. V. U., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22100 · Cited by 149 · see citing works

The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review

Rice, L., & Bisdas, S. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.07.014 · Cited by 150 · see citing works

Cognition, glucose metabolism and amyloid burden in Alzheimer's disease

Furst, A. J., Rabinovici, G. D., Rostomian, A. H., Steed, T., Alkalay, A., Racine, C. A., Miller, B. L., & Jagust, W. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.011 · Cited by 144 · see citing works

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease

Kadir, A., Marutle, A., Gonzalez, D., Schöll, M., Almkvist, O., Mousavi, M. T., Mustafiz, T., Darreh‐Shori, T., Nennesmo, I., & Nordberg, A. K. (2010) · Brain · doi:10.1093/brain/awq349 · Cited by 139 · see citing works

Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue

Ni, R., Gillberg, P., Bergfors, A., Marutle, A., & Nordberg, A. K. (2013) · Brain · doi:10.1093/brain/awt142 · Cited by 134 · see citing works

Cerebral amyloid PET imaging in Alzheimer’s disease

Jack, C. R., Barrio, J. R., & Kepe, V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1185-7 · Cited by 131 · see citing works

Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue

Choi, S., Schneider, J. A., Bennett, D. A., Beach, T. G., Bedell, B. J., Zehntner, S. P., Krautkramer, M. J., Kung, H. F., Skovronsky, D., Hefti, F. F., et al. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31821300bc · Cited by 129 · see citing works

Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk-prediction for Alzheimer dementia

Klunk, W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.006 · Cited by 134 · see citing works

Shift in brain metabolism in late onset Alzheimer’s disease: Implications for biomarkers and therapeutic interventions

Yao, J., Rettberg, J. R., Klosinski, L. P., Cadenas, E., & Brinton, R. D. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.005 · Cited by 124 · see citing works

Diagnostic accuracy of 18F-FDG and 11C-PIB-PET for prediction of short-term conversion to Alzheimer’s disease in subjects with mild cognitive impairment

Zhang, S., Han, D., Tan, X., Feng, J., Guo, Y., & Ding, Y. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02845.x · Cited by 121 · see citing works

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

Wolk, D. A., Zhang, Z., Boudhar, S., Clark, C. M., Pontecorvo, M. J., & Arnold, S. E. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302548 · Cited by 121 · see citing works

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline

Grundman, M., Pontecorvo, M. J., Salloway, S., Doraiswamy, P. M., Fleisher, A., Sadowsky, C., Nair, A. K., Siderowf, A. D., Lu, M., Arora, A., et al. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318279d02a · Cited by 119 · see citing works

Astrogliosis and impaired aquaporin‐4 and dystrophin systems in idiopathic normal pressure hydrocephalus

Eide, P. K., & Hansson, H. ‐. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12420 · Cited by 119 · see citing works

Poor Cognitive Outcome in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus

Koivisto, A. M., Alafuzoff, I. I., Savolainen, S., Sutela, A., Rummukainen, J. K., Kurki, M., Jääskeläinen, J. E., Soininen, H. S., Rinne, J., & Leinonen, V. (2012) · Neurosurgery · doi:10.1227/neu.0b013e31827414b3 · Cited by 116 · see citing works

Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus

Pyykkö, O. T., Lumela, M., Rummukainen, J. K., Nerg, O., Seppälä, T. T., Herukka, S., Koivisto, A. M., Alafuzoff, I. I., Puli, L., Savolainen, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091974 · Cited by 114 · see citing works

Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease

Ott, B. R., Initiative, T. A. D. N., Cohen, R. A., Gongvatana, A., Okonkwo, O. C., Johanson, C. E., Stopa, E. G., Donahue, J. E., & Silverberg, G. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1406 · Cited by 113 · see citing works

Aβ-amyloid and Tau Imaging in Dementia

Villemagne, V. L., Doré, V., Bourgeat, P., Burnham, S. C., Laws, S., Salvado, O., Masters, C. L., & Rowe, C. C. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.006 · Cited by 110 · see citing works

In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older Adults

Sojkova, J., Driscoll, I. F., Iacono, D., Zhou, Y., Codispoti, K.-E., Kraut, M. A., Ferrucci, L., Pletniková, O., Mathis, C. A., Klunk, W. E., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.357 · Cited by 112 · see citing works

Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease

Cohen, A. D., Landau, S. M., Snitz, B. E., Klunk, W. E., Blennow, K., & Zetterberg, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.004 · Cited by 107 · see citing works

Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes.

Pomeraniec, I. J., Bond, A. E., Lopes, M. B., & Jane, J. (2016) · Journal of Neurosurgery · doi:10.3171/2015.2.jns142318 · Cited by 94 · see citing works

Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia

Hu, W. T., McMillan, C. T., Libon, D. J., Leight, S., Forman, M. S., Lee, V. M.-Y., Trojanowski, J. Q., & Grossman, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ed9c52 · Cited by 102 · see citing works

Post‐mortem findings in 10 patients with presumed normal‐pressure hydrocephalus and review of the literature

Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J., Sutela, A., Vanninen, R. L., Jääskeläinen, J. E., Soininen, H. S., & Alafuzoff, I. I. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01195.x · Cited by 99 · see citing works

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease

Vandenberghe, R., Adamczuk, K., Dupont, P., Laere, K. V., & Chételat, G. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.014 · Cited by 99 · see citing works

Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta

Cohen, A. D., Rabinovici, G. D., Mathis, C. A., Jagust, W. J., Klunk, W. E., & Ikonomović, M. D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00002-7 · Cited by 99 · see citing works

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

Ikonomović, M. D., Buckley, C. J., Heurling, K., Sherwin, P. F., Jones, P. A., Zanette, M., Mathis, C. A., Klunk, W. E., Chakrabarty, A., Ironside, J. W., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0399-z · Cited by 98 · see citing works

Imaging normal pressure hydrocephalus: theories, techniques, and challenges

Keong, N. C. H., Peña, A., Price, S. J., Czosnyka, M., Czosnyka, Z. H., & Pickard, J. D. (2016) · Neurosurgical FOCUS · doi:10.3171/2016.7.focus16194 · Cited by 97 · see citing works

PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease

Rosen, R. F., Walker, L. C., & LeVine, H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.011 · Cited by 97 · see citing works

PET/CT in diagnosis of dementia

Berti, V., Pupi, A., & Mosconi, L. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06015.x · Cited by 95 · see citing works

Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid

Weigand, S. D., Vemuri, P., Wiste, H. J., Senjem, M. L., Pankratz, V. S., Aisen, P. S., Weiner, M. W., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., et al. (2011) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2010.08.230 · Cited by 93 · see citing works

Deep learning enables ultraviolet photoacoustic microscopy based histological imaging with near real-time virtual staining

Kang, L., Li, X., Zhang, Y., & Wong, T. T. W. (2021) · Photoacoustics · doi:10.1016/j.pacs.2021.100308 · Cited by 93 · see citing works

Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review

Kepe, V., Moghbel, M. C., Långström, B., Zaidi, H., Vinters, H. V., Huang, S., Satyamurthy, N., Doudet, D. J., Mishani, E., Cohen, R. M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130485 · Cited by 86 · see citing works

Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study

Ikonomovic, M., Abrahamson, E., Price, J., Hamilton, R., Mathis, C., Paljug, W. R., Debnath, M., Cohen, A., Mizukami, K., Dekosky, S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0943-2 · Cited by 90 · see citing works

Imaging Brain Effects of APOE4 in Cognitively Normal Individuals Across the Lifespan

Fouquet, M., Besson, F. L., Gonneaud, J., Joie, R. L., & Chételat, G. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9263-8 · Cited by 83 · see citing works

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

Rinne, J. O., Wong, D. F., Wolk, D. A., Leinonen, V., Arnold, S. E., Buckley, C. J., Smith, A. P. L., McLain, R. W., Sherwin, P. F., Farrar, G., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1051-z · Cited by 82 · see citing works

Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer’s disease

Rosen, R. F., Ciliax, B. J., Wingo, T. S., Gearing, M., Dooyema, J. M., Lah, J. J., Ghiso, J. A., LeVine, H., & Walker, L. C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0583-3 · Cited by 82 · see citing works

Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease

Chételat, G., Ossenkoppele, R., Villemagne, V. L., Perrotin, A., Landeau, B., Mézenge, F., Jagust, W. J., Dore, V., Miller, B. L., Egret, S., et al. (2016) · Brain · doi:10.1093/brain/aww159 · Cited by 80 · see citing works

Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.

Egefjord, L., Gejl, M., Møller, A., Brændgaard, H., Gottrup, H., Antropova, O., Møller, N., Poulsen, H. E., GJEDDE, A. H., Brock, B., et al. (2012) · PubMed · Cited by 80 · see citing works

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications

Laforce, R., & Rabinovici, G. D. (2011) · Alzheimer's Research &amp; Therapy · doi:10.1186/alzrt93 · Cited by 79 · see citing works

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status

Campbell, M. R., Ashrafzadeh‐Kian, S., Petersen, R. C., Mielke, M. M., Syrjanen, J. A., van Harten, A. C., Lowe, V. J., Jack, C. R., Bornhorst, J. A., & Algeciras‐Schimnich, A. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12190 · Cited by 74 · see citing works

Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later

Joutsa, J., Rinne, J. O., Hermann, B. P., Karrasch, M., Anttinen, A., Shinnar, S., & Sillanpää, M. L. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.6091 · Cited by 75 · see citing works

Cortical Brain Biopsy in Long-Term Prognostication of 468 Patients with Possible Normal Pressure Hydrocephalus

Leinonen, V., Koivisto, A. M., Alafuzoff, I. I., Pyykkö, O. T., Rummukainen, J. K., zu Fraunberg, M. V. U., Jääskeläinen, J. E., Soininen, H. S., Rinne, J., & Savolainen, S. (2012) · Neurodegenerative Diseases · doi:10.1159/000335155 · Cited by 73 · see citing works

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease

Villemagne, V. L., McLean, C., Reardon, K. A., Boyd, A., Lewis, V., Klug, G. M., Jones, G. R., Baxendale, D., Masters, C. L., Rowe, C. C., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.171496 · Cited by 67 · see citing works

¹¹ C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)

Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., & Feng, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010386.pub2 · Cited by 66 · see citing works

Use of amyloid-PET to determine cutpoints for CSF markers

Zwan, M. D., Rinne, J. O., Hasselbalch, S. G., Nordberg, A. K., Lleó, A., Herukka, S., Soininen, H. S., Law, I. G., Bahl, J. M. C., Carter, S. F., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002081 · Cited by 66 · see citing works

FDG-PET and amyloid-PET imaging

Perani, D. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000109 · Cited by 66 · see citing works

Comparison of CSF Distribution between Idiopathic Normal Pressure Hydrocephalus and Alzheimer Disease

Yamada, S., Ishikawa, M., & Yamamoto, K. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4695 · Cited by 65 · see citing works

Impact of Beta-Amyloid-Specific Florbetaben PET Imaging on Confidence in Early Diagnosis of Alzheimer’s Disease

Schipke, C. G., Peters, O., Heuser, I., Grimmer, T., Sabbagh, M. N., Sabri, O., Hock, C., Kunz, M., Kuhlmann, J., Reininger, C. B., et al. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000339367 · Cited by 63 · see citing works

Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia

Kadir, A., & Nordberg, A. K. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077164 · Cited by 64 · see citing works

Update on Amyloid Imaging: From Healthy Aging to Alzheimer's Disease

Wolk, D., & Klunk, W. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0051-4 · Cited by 75 · see citing works

Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis

Rowe, C. C., & Villemagne, V. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.017 · Cited by 61 · see citing works

Clinical Amyloid Imaging

Mallik, A. K., Drzezga, A. E., & Minoshima, S. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.005 · Cited by 62 · see citing works

A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis

Perani, D., Schillaci, O., Padovani, A., Nobili, F. M., Iaccarino, L., Pasquale, D. R., Frisoni, G. B., & Caltagirone, C. (2014) · BioMed Research International · doi:10.1155/2014/785039 · Cited by 59 · see citing works

Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease

Villemagne, V. L., Klunk, W. E., Mathis, C. A., Rowe, C. C., Brooks, D. J., Hyman, B. T., Ikonomović, M. D., Ishii, K., Jack, C. R., Jagust, W. J., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2045-0 · Cited by 58 · see citing works

Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development

Nordberg, A. K. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt96 · Cited by 58 · see citing works

Evolution of Brain Imaging Instrumentation

Abraham, T., & Feng, J. D. (2011) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2010.12.001 · Cited by 55 · see citing works

Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau

Ray, B., Reyes, P. F., & Lahiri, D. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.07.011 · Cited by 51 · see citing works

Is there a neuropathology difference between mild cognitive impairment and dementia?

Haroutunian, V. H., Hoffman, L. B., & Been, M. S. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/vharoutunian · Cited by 49 · see citing works

Preclinical Alzheimer’s disease biomarkers accurately predict cognitive and neuropathological outcomes

Long, J. M., Coble, D. W., Xiong, C., Schindler, S. E., Perrin, R. J., Gordon, B. A., Benzinger, T. L. S., Grant, E., Fagan, A. M., Harari, O., et al. (2022) · Brain · doi:10.1093/brain/awac250 · Cited by 46 · see citing works

PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease

Pontecorvo, M. J., & Mintun, M. A. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt70 · Cited by 49 · see citing works

Alzheimer’s disease pathology and shunt surgery outcome in normal pressure hydrocephalus

Yaşar, S., Jusué-Torres, I., Lu, J. Y., Robison, J., Patel, M. A., Crain, B. J., Carson, K. A., Hoffberger, J. B., Batra, S., Sankey, E. W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182288 · Cited by 48 · see citing works

Advances in Brain Amyloid Imaging

Krishnadas, N., Villemagne, V. L., Doré, V., & Rowe, C. C. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.005 · Cited by 48 · see citing works

An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients

Wong, D. F., Moghekar, A., Rigamonti, D., Brašić, J. R., ROUSSET, O. G., Willis, W. D., Buckley, C. J., Smith, A. P. L., Gok, B., Sherwin, P. F., et al. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0583-x · Cited by 45 · see citing works

Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET

Matsuda, H., Yoko, S., & Sato, N. (2019) · Japanese Journal of Radiology · doi:10.1007/s11604-019-00867-7 · Cited by 40 · see citing works

High-speed label-free ultraviolet photoacoustic microscopy for histology-like imaging of unprocessed biological tissues

Li, X., Kang, L., Zhang, Y., & Wong, T. T. W. (2020) · Optics Letters · doi:10.1364/ol.401643 · Cited by 44 · see citing works

Positron emission tomography with [ 18 F]flutemetamol and [ 11 C] PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients

Leinonen, V., Rinne, J. O., Virtanen, K. A., Eskola, O., Rummukainen, J., Huttunen, J., zu Fraunberg, M. V. U., Nerg, O., Koivisto, A. M., Rinne, J., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12102 · Cited by 43 · see citing works

Diagnostic biomarkers in Alzheimer’s disease

Andersen, E., Casteigne, B., Chapman, W. D., Creed, A., Foster, F., Lapins, A., Shatz, R., & Sawyer, R. P. (2021) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2021.100041 · Cited by 42 · see citing works

In Vivo SPECT Imaging of Amyloid-β Deposition with Radioiodinated Imidazo[1,2-a]Pyridine Derivative DRM106 in a Mouse Model of Alzheimer's Disease

Chen, C.-J., Bando, K., Ashino, H., Taguchi, K., Shiraishi, H., Shima, K., Fujimoto, O., Kitamura, C., Matsushima, S., Uchida, K., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.146944 · Cited by 42 · see citing works

DTI-MRI biomarkers in the search for normal pressure hydrocephalus aetiology: a review

Hoza, D., Vlasák, A., Hořínek, D., Sameš, M., & Alfieri, A. (2014) · Neurosurgical Review · doi:10.1007/s10143-014-0584-0 · Cited by 41 · see citing works

P1‐369: Brain [11C]‐PIB uptake reflects beta‐amyloid burden detected by immunohistochemistry in frontal cortex biopsy specimens

Rinne, J. O. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.649

Early Detection of Alzheimer's Disease Beta-amyloid Pathology -Applicability of Positron Emission Tomography with the Amyloid Radioligand 11C-PIB

Scheinin, N. M. (2010) · UTUPub (University of Turku)

Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study

Ikonomovic, M., Abrahamson, E., Price, J., Hamilton, R., Mathis, C., Paljug, W. R., Debnath, M., Cohen, A., Mizukami, K., Dekosky, S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0943-2 · Cited by 90 · see citing works

Amyloid β Accumulation Assessed with 11C-Pittsburgh Compound B PET and Postmortem Neuropathology

Hatsuta, H., Takao, M., Ishii, K., Ishiwata, K., Saito, Y., Kanemaru, K., Arai, T., Suhara, T., Shimada, H., Shinotoh, H., et al. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150302155930 · Cited by 13 · see citing works

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works